The USFDA inspection focused on evaluating the facility's adherence to global regulatory requirements and best practices
Finerenone is the first mineralocorticoid receptor (MR) antagonist to demonstrate definitive cardiovascular benefits in a Phase III study in patients with heart failure (HF) with a left ventricular ejection fraction (LVEF) of ?40%
First patient enrolled in the Phase III SOHO-02 trial of investigational agent BAY 2927088 in treatment-naïve patients with advanced NSCLC with HER2-activating mutations
The grant is designated for the research and development of Pyronaridine
This partnership aims to accelerate research and development into innovative treatments and, if successful, will generate milestones and royalties
Stringent regulatory environments can make OEMs reluctant to change processes and materials for approved medical devices
The emergence of new infections in India is a growing concern
In a Phase 3 trial, Pfizer and BioNTech’s combination vaccine candidate against influenza and COVID-19 met one of its two primary immunogenicity objectives
These results add to the growing body of evidence indicating a single dose of ABRYSVO provides strong immune protection against outcomes caused by RSV
He advocated for a "PPP + PPP" collaboration, urging the public and private sectors within India to partner with their counterparts in other countries
Subscribe To Our Newsletter & Stay Updated
